Cargando…
Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
Autores principales: | Call, Jerry W., Wang, Yu, Montoya, Denisse, Scherzer, Norman J., Heinrich, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503372/ https://www.ncbi.nlm.nih.gov/pubmed/31080577 http://dx.doi.org/10.1186/s13569-019-0117-2 |
Ejemplares similares
-
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
por: Call, Jerry W., et al.
Publicado: (2019) -
Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry
por: Call, Jerry, et al.
Publicado: (2012) -
Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) – a survey of life raft group members
por: Montoya, Denisse, et al.
Publicado: (2022) -
Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
por: Sako, Hiroyuki, et al.
Publicado: (2014) -
Reintroduction of Imatinib in GIST
por: Reid, T.
Publicado: (2013)